Dassault BIOVIA

BIOVIA is Dassault Systemes' scientific research and development portfolio, spanning biological, chemical and material industries rather than pharmaceuticals alone. That breadth is its defining characteristic: the same modelling and informatics foundation serves drug discovery, materials science and formulation work, which suits organisations whose research crosses those boundaries. The vendor states thousands of companies use it, and positions the goal as redefining the speed of research and development.

The current emphasis is generative AI applied to science. BIOVIA Scientific AI is described as giving every scientist generative technology to design faster, experiment virtually and create more successful products through AI-powered Virtual Twins, the digital counterparts of physical experiments that let candidates be assessed before laboratory work begins. A partnership with NVIDIA combines accelerated AI inference with the vendor's scientific modelling, aimed at next-generation therapeutics and high-performance materials. MARIE is an AI virtual companion within the portfolio.

The named products cover distinct research jobs. Discovery Studio and Materials Studio handle simulation for biological and materials work respectively. Generative Therapeutics Design targets novel therapy candidates. Pipeline Pilot is the scientific workflow and data pipelining tool. ONE Lab covers laboratory operations. Disciplines addressed include biosciences, laboratory informatics, materials science engineering, regulatory management, scientific informatics and quality management, with the AI-Ready Lab theme focused on producing high-quality, AI-ready data from the point of capture using a unified data model. Everything runs on the open, collaborative 3DEXPERIENCE platform. Contract research services and training are offered alongside the software, and industry solutions extend to consumer packaged goods, retail, infrastructure, energy and transportation. Pricing is not published.